JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Last updated: 01 November 2019
Ocrevus (ocrelizumab), the first-ever FDA approved medicine for primary progressive MS has now also been approved by the EMA.Read more
